Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.26.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2026
Stock-Based Compensation [Abstract]  
Schedule of Activity for Stock Options

The following table summarizes activity for stock options under all plans for the nine months ended September 30, 2026:

 

                Weighted-        
    Number of           Average        
    Shares     Weighted-     Remaining     Aggregate  
    Underlying     Average     Contractual     Intrinsic  
    Outstanding     Exercise     Term     Value  
    Options     Price     (in Years)     (in thousands)  
Outstanding, December 31, 2025     2,033,114     $ 8.31       8.23     $ 10,347  
Options granted     60,000     $ 5.05       9.93     $ -  
Options forfeited     (79.019 )   $ -       -     $ -  
Options exercised     -     $ -       -     $ -  
Outstanding, September 30, 2026     2,014,096     $ 8.29       7.54     $ 115  
                                 
Options vested and exercisable as of September 30, 2026     1,306,292     $ 9.44       7.08     $ 79  
Schedule of Restricted Stock Options

The following table summarizes activity for restricted stock options under all plans for the nine months ended September 30, 2026:

 

    Number of        
    Shares     Weighted-  
    Underlying     Average  
    Outstanding     Exercise  
    RSUs     Price  
Outstanding, December 31, 2025     3,677       4.29  
RSUs granted     1,678,762       7.91  
RSUs vested     (239,896 )     8.53  
RSUs withheld     (107,578 )     8.56  
Outstanding, September 30, 2026     1,334,965     $ 7.73  
Schedule of Stock-Based Compensation Expense

The Company has recorded stock-based compensation expense, which includes expense related to restricted stock units, allocated by functional cost as follows for the three and nine months ended September 30, 2025, and 2026 (in thousands):

 

    Three Months Ended     Nine months ended  
    September 30,     September 30,  
    2025     2026     2025     2026  
                         
Research and development   $ 326     $ 805     $ 849     $ 2,275  
General and administrative     403       1,000       1,014       3,161  
Total stock-based compensation   $ 729     $ 1,805     $ 1,863     $ 5,436  
Schedule of Fair Value of Awards Granted

The following averaged assumptions were used to calculate the fair value of awards granted to employees, directors and non-employees for the nine months ended September 30, 2025 and September 30, 2026:

 

    Nine Months
Ended
September 30,
2025
    Nine Months
Ended
September 30,
2026
 
                 
Expected volatility     107.44% - 116.14%       107.44% - 139.22%  
Risk-free interest rate     3.75% - 4.38%       3.75% - 4.61%  
Dividend yield     -%       -%  
Expected term     6.25 years       5.50 years - 6.50 years